07
May
Dr Reddy's Laboratories on Tuesday reported a 36% rise in its consolidated profit after tax to Rs 1,307 Crore for the quarter ending March 2024 due to strong sales in the US market. The Hyderabad-based drug major had reported a profit after tax of Rs 959 Crore in the January-March quarter of financial year 2022-23. Revenue increased to Rs 7,083 Crore in the period under review from Rs 6,297 Crore in Q4FY13. For the full year ending March 31, 2024, the drug major said its PAT increased to Rs 5,568 Crore compared to Rs 4,507 Crore in financial year 2022-23.…